© APA / AFP / Ritzau Scanpix / LISELOTTE SABROE / LISELOTTE SABROE
“I just remind you that we expected 120 million cans in Q1, and in the end we got 30 million,” said Breton, referring to the first quarter of 2021. “So we had a problem with this company.” Breton asked clear that there are no problems with other manufacturers. Biontech / Pfizer and Moderna even exceeded their commitments to the EU.
On Wednesday, the EU tightened its supervision of coronavirus vaccine exports and gained more opportunities to block deliveries to countries that have higher vaccination rates, such as the UK, or that do not leave the vaccine doses produced in each country out of the country.
Breton commented on a visit to the pharmaceutical company Reig Jofre in Barcelona, which is due to fill the Johnson & Johnson vaccine from mid-June. Europe should be the world leader in coronavirus vaccine production by the end of the year, Breton said. 52 production sites are involved in the process across the continent. In the summer, possibly around mid-July, the EU could have vaccinated enough people to achieve “global immunity”.